ATENTO S A ATTO
SHS · Common Stock · CUSIP L0427L105
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSan Carlos, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.85.
Trends to Q2 2020
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 30 |
| Q1 2020 | 26 |
| Q2 2020 | 24 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 8 | 15 |
| Q2 2020 | 3 | 14 |
Biggest buyers
| Plaisance Capital LLC | Added | +95.0k |
| Eidelman Virant Capital | New | +35.6k |
| ROYAL BANK OF CANADA | Added | +84 |
Biggest sellers
| Bain Capital Investors LLC | Reduced | -46.8m |
| WELLINGTON MANAGEMENT GROUP LLP | Sold out | -346.0k |
| GOLDMAN SACHS GROUP INC | Reduced | -64.5k |
| LPL Financial LLC | Sold out | -50.0k |
| MORGAN STANLEY | Reduced | -45.8k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -30.2k |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Reduced | -23.7k |
| TWO SIGMA ADVISERS, LP | Reduced | -19.7k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -15.3k |
| Tower Research Capital LLC (TRC) | Reduced | -7.5k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Frazier Life Sciences Public Fund, L.P.
13D · may seek influence
new · filed 2026-08-11
Stated purposeThe Reporting Persons acquired the Common Stock reported herein for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, the Reporting Persons may dispose of or acquire additional shares of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the … Full filing |
13.5% |
| Deep Track Capital, LP 13G · passive investor new · filed 2026-08-12 | 7.5% |
Insider purchases and sales in Q2 2020
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2020.
Holders, Q2 2020
| Manager | Shares | Change |
|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.06% of their portfolio | 11.2m $7.7m | Not comparable |
| Bain Capital Investors LLC 0.25% of their portfolio | 1.8m $2.1m | Reduced -46.8m |
| MORGAN STANLEY 0.00% of their portfolio | 650.4k $768.0k | Reduced -45.8k |
| Equinox Partners Investment Management LLC 0.45% of their portfolio | 635.9k $750.4k | Unchanged |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 628.1k $745.0k | Reduced -5.6k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 553.3k $653.0k | Unchanged |
| Plaisance Capital LLC 0.42% of their portfolio | 332.2k $392.0k | Added +95.0k |
| ROYCE & ASSOCIATES LP 0.00% of their portfolio | 109.3k $129.0k | Unchanged |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 104.4k $123.0k | Reduced -19.7k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 103.6k $122.0k | Reduced -64.5k |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.00% of their portfolio | 102.9k $121.0k | Reduced -23.7k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 76.4k $90.0k | Unchanged |
| California Public Employees Retirement System 0.00% of their portfolio | 64.3k $76.0k | Reduced -2.4k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 52.7k $62.0k | Reduced -4.7k |
| Eidelman Virant Capital 0.03% of their portfolio | 35.6k $42.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 31.1k $37.0k | Unchanged |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 22.9k $27.0k | Reduced -3.4k |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 17.5k $21.0k | Unchanged |
| DIVERSIFIED TRUST CO 0.00% of their portfolio | 10.1k $12.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 3.8k $4.0k | Unchanged |
| Investors Research Corp 0.00% of their portfolio | 2.5k $3.0k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 2.0k $2.0k | Added +84 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.0k $1.0k | Reduced -7.5k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |